SCHEMBL7517060

SCHEMBL7517060

CCS(=O)(=O)Nc1ccc2nc(C(O)c3ccc(Oc4ccccc4)cc3)[nH]c2c1

nearest known ligand 0.65

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 7/20 0.65
GRIN2B Q13224 7/20 0.65
MLKL Q8NB16 2/20 0.43
PTGES O14684 1/20 0.41
ALOX5 P09917 1/20 0.41
LTC4S Q16873 1/20 0.41
MEN1 O00255 1/20 0.41
HTT P42858 1/20 0.41
KMT2A Q03164 1/20 0.41
MAPT P10636 1/20 0.41
KDR P35968 1/20 0.41
TEK Q02763 1/20 0.41
CHEK2 O96017 2/20 0.40
MET P08581 1/20 0.40
PGR P06401 1/20 0.40
CSNK1A1 P48729 1/20 0.39
CSNK1D P48730 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7511793 0.90 GRIN1 (0.63) GRIN1GRIN2BMLKLPTGESALOX5
SCHEMBL7516433 0.88 GRIN1 (0.66) GRIN1GRIN2BMLKLPTGESALOX5
SCHEMBL7508541 0.79 GRIN1 (0.57) GRIN1GRIN2BMLKLPTGESALOX5
SCHEMBL7456255 0.72 GRIN1 (1.00) GRIN1GRIN2B
SCHEMBL7452272 0.71 GRIN1 (0.89) GRIN1GRIN2B
SCHEMBL7452878 0.69 GRIN1 (1.00) GRIN1GRIN2BPGR
SCHEMBL7512484 0.69 GRIN1 (0.64) GRIN1GRIN2BCHEK2PGR
SCHEMBL4237754 0.69 GRIN1 (0.54) GRIN1GRIN2BMEN1HTTKMT2A
SCHEMBL4237749 0.67 GRIN1 (0.50) GRIN1GRIN2BMEN1KMT2ACHEK2
SCHEMBL24953738 0.67 KDM4E (0.60) GRIN1GRIN2BPTGESALOX5LTC4S

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242076-A4 2-BENZYL AND 2-HETEROARYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS MERCK & CO INC (US) 2002-11-27 EP disclosed
EP-1242076-A1 2-BENZYL AND 2-HETEROARYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS Merck & Co., Inc. (US) 2002-09-25 EP disclosed
WO-2001032174-A1 2-BENZYL AND 2-HETEROARYL BENZIMIDAZOLE NMDA/NR2B ANTAGONISTS MERCK & CO., INC. (US) 2001-05-10 WO disclosed